Bank Of New York Mellon Corp Enochian Biosciences Inc Transaction History

Bank Of New York Mellon Corp

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 09, 2023	BUY	$0.91 - $1.31 $50,054 - $72,056	55,005 New	55,005 $50.3 Million
Q4 2022 Feb 14, 2023	BUY	$1.03 - $2.13 $56,655 - $117,160	55,005 New	55,005 $56,000
Q3 2022 Nov 14, 2022	BUY	$1.7 - $2.86 $9,489 - $15,964	5,582 Added 11.29%	55,005 $99,000
Q2 2022 Aug 15, 2022	BUY	$1.93 - $8.73 $75,065 - $339,544	38,894 Added 369.4%	49,423 $95,000
Q3 2021 Nov 12, 2021	SELL	$4.56 - $7.88 $3,866 - $6,682	-848 Reduced 7.45%	10,529 $71,000
Q2 2021 Aug 11, 2021	SELL	$2.94 - $6.79 $119,475 - $275,932	-40,638 Reduced 78.13%	11,377 $56,000
Q1 2021 May 13, 2021	SELL	$3.02 - $4.51 $449 - $671	-149 Reduced 0.29%	52,015 $184,000
Q4 2020 Feb 09, 2021	SELL	$2.82 - $3.55 $3,178 - $4,000	-1,127 Reduced 2.11%	52,164 $153,000
Q3 2020 Nov 12, 2020	BUY	$3.42 - $4.55 $2,072 - $2,757	606 Added 1.15%	53,291 $190,000
Q2 2020 Aug 12, 2020	BUY	$2.78 - $6.06 $41,877 - $91,287	15,064 Added 40.04%	52,685 $221,000
Q1 2020 May 06, 2020	BUY	$2.08 - $5.41 $28,793 - $74,890	13,843 Added 58.22%	37,621 $112,000
Q4 2019 Feb 14, 2020	BUY	$3.48 - $6.75 $82,747 - $160,501	23,778 New	23,778 $119,000

14M

33.7K

Ticker ENOB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 52,950,000
Market Cap $244M
Description
Enochian Biosciences, Inc., a pre-clinical stage biotechnology company, engages in the research and development of pharmaceutical and biological products for the human treatment of human immunodeficiency virus (HIV), hepatitis B virus (HBV), influenza and coronavirus infections, and cancer. The company's lead candidate includes ENOB-HV-01 for au...

Get notified when there are updates to the investment portfolio of Bank Of New York Mellon Corp, based on Form 13F filings with the SEC.

Stay updated on Bank Of New York Mellon Corp with notifications on news.